These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3617017)

  • 1. Biphasic platelet aggregation in rat plasma and the effect of calcium flux modulators.
    Emery M; O'Dell BL
    Thromb Res; 1987 May; 46(4):617-23. PubMed ID: 3617017
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of platelet aggregation by verapamil: quantification by in vivo and in vitro techniques.
    Ribeiro LG; Brandon TA; Horak JK; Ware JA; Miller RR; Solis RT
    J Cardiovasc Pharmacol; 1982; 4(2):170-3. PubMed ID: 6175797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-aggregatory actions of calcium channel blockers in cat platelets.
    Schmunk GA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):179-87. PubMed ID: 6803310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental research on the action of isoptin and alkylenediamine derivatives on the aggregation capacity and the membrane-bound calcium level of thrombocytes].
    Mironiuk EP; Manevich EM; Piotrovskiĭ LB; Dumpis MA
    Farmakol Toksikol; 1987; 50(2):42-6. PubMed ID: 3582633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.
    Ware JA; Johnson PC; Smith M; Salzman EW
    Circ Res; 1986 Jul; 59(1):39-42. PubMed ID: 3089642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
    Onoda JM; Sloane BF; Honn KV
    Thromb Res; 1984 Jun; 34(5):367-78. PubMed ID: 6377570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers.
    Moore JB; Fuller BL; Falotico R; Tolman EL
    Thromb Res; 1985 Nov; 40(3):401-11. PubMed ID: 2417362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiaggregatory activity of N-methyl- and N-isobutyl-1,2-diphenyl ethanolamines in rat platelets.
    el Tahir KE; el-Naser MA; Ageel AM; el-Obeid HA; al-Rashood KA
    Arch Int Pharmacodyn Ther; 1990; 307():162-71. PubMed ID: 2095711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
    Kiyomoto A; Sasaki Y; Odawara A; Morita T
    Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of heparin and platelet aggregation].
    Escolar G; Villaverde CA; Almirall L; Borruel MT; Hernández MR
    Arch Farmacol Toxicol; 1981 Apr; 7(1):93-6. PubMed ID: 7325723
    [No Abstract]   [Full Text] [Related]  

  • 11. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
    Glusa E; Bevan J; Heptinstall S
    Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of citrate concentration is necessary in platelet aggregometry studies in uremia.
    Rylance PB; Gordge MP; Weston MJ
    Clin Nephrol; 1985 Mar; 23(3):155-6. PubMed ID: 3987105
    [No Abstract]   [Full Text] [Related]  

  • 13. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
    Jones CR; Pasanisi F; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1985 Sep; 20(3):191-6. PubMed ID: 2994701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium blockers: antiatherogenic action by influencing the prostaglandin-system.
    Weiss K; Fitscha P; Gazsó A; Gludovacz D; Sinzinger H
    Prog Clin Biol Res; 1989; 301():353-7. PubMed ID: 2529552
    [No Abstract]   [Full Text] [Related]  

  • 16. Hirudin and platelets.
    Glusa E
    Semin Thromb Hemost; 1991 Apr; 17(2):122-5. PubMed ID: 1771409
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenosine diphosphate induced platelet aggregation and release reaction in heparinized platelet rich plasma and the influence of added citrate.
    Heptinstall S; Mulley GP
    Br J Haematol; 1977 Aug; 36(4):565-71. PubMed ID: 889719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of calcium in epinephrine or ADP potentiation of human platelet aggregation.
    Owen NE; Le Breton GC
    Thromb Res; 1980 Mar; 17(6):855-63. PubMed ID: 7404491
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of adenosine diphosphate and calcium chelation on platelet aggregation testing in patients receiving clopidogrel therapy.
    Patel P; Gonzalez R; Dokainish H; Lakkis N
    J Am Coll Cardiol; 2006 Jan; 47(2):464-5. PubMed ID: 16412878
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of calcium channel blockers and insulin on the platelet function in patients with diabetes mellitus.
    Lee YS; Hahm K; Lee SY
    Yonsei Med J; 1986; 27(2):132-7. PubMed ID: 3529654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.